Honz Pharmaceutical Co., Ltd. (300086.SZ) SHZ
7.09
-0.13(-1.80%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
7.09
-0.13(-1.80%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
751
First IPO Date
May 26, 2010
| Name | Title | Pay | Year Born |
| Dexin Lin | Vice President & Board Secretary | 0 | 1980 |
| Jiangtao Hong | President | 0 | 1970 |
| Yong Wang | Assistant to the Chairman | 0 | 1977 |
| Jing Li | Chief Financial Officer & Accounting Supervisor | 0 | 1982 |
| Liping Hong | Vice Chairman & Vice President | 0 | 1968 |
Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pediatric medicines in China. It offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine. The company markets its products through a network of agents and sales terminals. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. is headquartered in Guangzhou, China.